Editorial: Why are guidelines not followed in clinical practice?

This publication has 10 references indexed in Scilit:

• Treatment of metastatic breast cancer in EU: Analysis of market research data from 4Q2013 till 3Q2014
  The Breast, 2017
• Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
  The Breast, 2017
• Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
  Journal of Clinical Oncology, 2016
• In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium
  Annals of Oncology, 2016
• Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer
  Surgery Today, 2015
• Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
  Journal of Clinical Oncology, 2014
• 1st International consensus guidelines for advanced breast cancer (ABC 1)
  The Breast, 2012
• 453 Trends in survival in metastatic breast cancer
  European Journal of Cancer Supplements, 2010
• Selecting High Priority Quality Measures For Breast Cancer Quality Improvement
  Medical Care, 2008
• Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast Cancer
  Journal of Clinical Oncology, 2004